Operating Lease, Right-of-Use Asset of Coeptis Therapeutics Holdings, Inc. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Coeptis Therapeutics Holdings, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
Coeptis Therapeutics Holdings, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $29,104, a 58% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Coeptis Therapeutics Holdings, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$29,104	-$40,450	-58%	30 Sep 2025	10-Q	14 Nov 2025	2025	Q3
Q2 2025	$39,564	-$39,540	-50%	30 Jun 2025	10-Q	14 Aug 2025	2025	Q2
Q1 2025	$49,789	-$9,994	-17%	31 Mar 2025	10-Q	14 May 2025	2025	Q1
Q4 2024	$59,783	-$37,788	-39%	31 Dec 2024	10-Q	14 Nov 2025	2025	Q3
Q3 2024	$69,554	+$40,878	+143%	30 Sep 2024	10-Q	13 Nov 2024	2024	Q3
Q2 2024	$79,104	+$40,117	+103%	30 Jun 2024	10-Q	16 Aug 2024	2024	Q2
Q1 2024	$59,783	+$10,718	+22%	31 Mar 2024	10-Q	14 May 2025	2025	Q1
Q4 2023	$97,571	+$38,657	+66%	31 Dec 2023	10-K	28 Mar 2025	2024	FY
Q3 2023	$28,676			30 Sep 2023	10-Q/A	16 Aug 2024	2023	Q3
Q2 2023	$38,987			30 Jun 2023	10-Q/A	25 Mar 2024	2023	Q2
Q1 2023	$49,065			31 Mar 2023	10-Q/A	25 Mar 2024	2023	Q1
Q4 2022	$58,914	+$40,989	+229%	31 Dec 2022	10-K/A	16 Aug 2024	2023	FY
Q4 2021	$17,925			31 Dec 2021	10-K/A	25 Mar 2024	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.